AbbVie (MEX:ABBV) GF Score: 72/100 (As of Jul. 03, 2026) — 10% Below Median


MEX:ABBV AbbVie Inc MEX:ABBV
72 GF Score
Price MXN4,402.62
GF Value MXN3,571.24
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is AbbVie GF Score?

AbbVie MEX:ABBV 72 GF Score is 72 as of Jul. 03, 2026, which is 10% below its 10-year median of 80.00. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,571.24 (Modestly Overvalued). The stock has 4 warning signs investors should review.

AbbVie has the GF Score of 72, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 7/10
3. Growth Rank : 4/10
4. GF Value Rank : 6/10
5. Momentum Rank : 9/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes AbbVie is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

AbbVie  (MEX:ABBV) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

AbbVie GF Score Related Terms

MEX:ABBV vs MRK, JNJ, AMGN: GF Score Comparison

For the Drug Manufacturers - General subindustry, AbbVie's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's GF Score distribution charts can be found below:

* The bar in red indicates where AbbVie's GF Score falls into.


MEX:ABBV
72GF Score
AbbVie Inc MEX:ABBV
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 72 mean?
AbbVie (MEX:ABBV) has a GF Score of 72 as of Jul. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on AbbVie and its competitors. This is 10% below median its historical median of 80.00. Over the past decade, AbbVie's GF Score has ranged from 56.00 to 95.00.
Is AbbVie's GF Score too high?
AbbVie's current GF Score of 72 is 10% below median its 10-year median of 80.00. Over the past 10 years, this metric has ranged from a low of 56.00 to a high of 95.00. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's GF Score compare to MRK and JNJ?
AbbVie's GF Score of 72 can be compared against companies in the Drug Manufacturers industry. Historically, AbbVie's own GF Score has ranged from 56.00 to 95.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on AbbVie and its competitors. AbbVie's current GF Score is 72, which is 10% below median its own 10-year median of 80.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,571.24, compared to a current price of MXN4,402.62 — trading 23.3% above its estimated fair value. The current GF Score is 72, which is 10% below median its 10-year median of 80.00. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current GF Score is 72 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbbVie (MEX:ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of MXN4,402.62 is trading 23.3% above its estimated GF Value™ of MXN3,571.24. GuruFocus considers AbbVie to be Modestly Overvalued.

Key valuation signals for MEX:ABBV:

  • GF Score: 72 (10% below median its 10-year median of 80.00)
  • GF Value™: MXN3,571.24 vs. price of MXN4,402.62 (23.3% above fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score

Get the complete analysis for MEX:ABBV

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,402.62
Price
MXN3,571.24
GF Value